Home
Publications
News
About
Contact
Investor Relations
Select Page
Home
Publications
News
About
Contact
Investor Relations
All SEC Filings
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Board Diversity
Filing Type:
View All
10-K
10-Q
3
4
424B3
424B4
424B5
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
EFFECT
FWP
POS AM
PRE 14A
RW
S-1
S-1/A
S-3
S-8
S-8 POS
SC 13G
UPLOAD
Year:
View All
2024
2023
2022
2017
Date
Form
Description
PDF
XBRL
Pages
10/10/23
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
4
09/26/23
3
Initial statement of beneficial ownership of securities
Documents
expand_more
EX-24.1
2
09/25/23
3
Initial statement of beneficial ownership of securities
Documents
expand_more
EX-24.1
2
09/25/23
RW
Registration Withdrawal Request
1
09/20/23
S-1
General form of registration statement for all companies including face-amount certificate companies
Documents
expand_more
EX-1.1
EX-3.1
EX-3.3
EX-3.5
EX-4.9
EX-4.10
EX-4.11
EX-4.12
EX-4.13
EX-5.1
EX-23.2
EX-23.3
EX-FILING FEES
184
09/20/23
8-K
Current report filing
Documents
expand_more
EX-4.1
EX-4.2
EX-10.1
EX-10.2
EX-10.3
EX-10.4
EX-10.5
EX-10.6
EX-10.7
EX-10.8
EX-10.9
EX-10.10
EX-10.11
EX-10.12
EX-10.13
EX-23.1
EX-99.1
EX-99.2
EX-99.3
141
08/14/23
DRS
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
99
08/14/23
8-K
Current report filing
Documents
expand_more
EX-99.1
5
08/14/23
10-Q
Quarterly report pursuant to Section 13 or 15(d)
Documents
expand_more
EX-3.2
EX-3.4
EX-31.1
EX-31.2
EX-32.1
22
08/11/23
4
Statement of changes in beneficial ownership of securities
1
rss_feed
Filing RSS
arrow_back
1…
7
8
9
10
11
12
13
14
15
16
…22
arrow_forward
Email Alerts
Contacts
RSS News Feed
Phone
(210) 698-5334
Email
info@bioaffinitytech.com
LinkedIn
…/bioaffinitytechnologies
Twitter
@bioAffinity
Subscribe for News from bioAffinity Technologies
Subscribe